A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures

Objective: We assessed the efficacy, safety, and tolerability of cannabidivarin (CBDV) as add-on therapy in adults with inadequately controlled focal seizures. Materials and Methods: One hundred and sixty-two participants (CBDV n=81; placebo n=81) were enrolled. After a 4-week baseline, participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodie, Martin J., Czapinski, Piotr, Pazdera, Ladislav, Sander, Josemir W., Toledo, Manuel, Napoles, Mariana, Sahebkar, Farhad, Schreiber, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713263/
https://www.ncbi.nlm.nih.gov/pubmed/33998885
http://dx.doi.org/10.1089/can.2020.0075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713263/
https://www.ncbi.nlm.nih.gov/pubmed/33998885
http://dx.doi.org/10.1089/can.2020.0075

Ejemplares similares